Research on the Construction of Bispecific-Targeted Sustained-Release Drug-Delivery Microspheres and Their Function in Treatment of Hepatocellular Carcinoma

[Image: see text] Lenvatinib (LEN) is approved as one of the commonly used drugs in the treatment of hepatocellular carcinoma (HCC). It is recognized to be a novel therapeutic choice for the direct and targeted delivery of effective drugs to HCC tumor sites. The key to the proposed method lies in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zi−Li, Li, Feng, Zhang, Jun−Tao, Shi, Xiang−Jun, Xu, Yong−Hua, Huang, Xiu−Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244910/
https://www.ncbi.nlm.nih.gov/pubmed/35785307
http://dx.doi.org/10.1021/acsomega.2c02584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244910/
https://www.ncbi.nlm.nih.gov/pubmed/35785307
http://dx.doi.org/10.1021/acsomega.2c02584

Ejemplares similares